Neulasta Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Condition:   Medulloblastoma Interventions:   Procedure: Surgical resection;   Procedure: Ommaya/VPS;   Drug: Methotrexate;   Drug: Cisplatin;   Drug: Vincristine;   Drug: Cyclophosphamide;   Drug: Carboplatin;   Drug: Topotecan;   Drug: Etoposide;   Drug: Pegfilgrastim;   Drug: Filgrastim;   Radiation: Irradiation Sponsor:   St. Jude Children's Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2022 Category: Research Source Type: clinical trials